Weaver Consulting Group’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-27
Closed -$7K 628
2020
Q3
$7K Sell
27
-10
-27% -$2.59K ﹤0.01% 635
2020
Q2
$13K Hold
37
0.01% 469
2020
Q1
$10K Hold
37
0.01% 442
2019
Q4
$10K Hold
37
0.01% 494
2019
Q3
$16K Buy
37
+19
+106% +$8.22K 0.01% 390
2019
Q2
$10K Hold
18
0.01% 463
2019
Q1
$9K Buy
+18
New +$9K ﹤0.01% 973